Mednax Inc (MD)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 368,500 0 209,800 351,500 392,000
Total stockholders’ equity US$ in thousands 849,061 967,985 942,375 909,771 891,632 858,667 845,430 877,076 896,487 845,466 808,906 766,759 747,485 804,761 826,570 1,487,400 1,499,000 1,479,360 2,725,030 2,779,810
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.20 0.00 0.12 0.11 0.12

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $849,061K)
= 0.00

The debt-to-capital ratio of Pediatrix Medical Group Inc has exhibited fluctuations over the past eight quarters. The ratio, which represents the proportion of debt in relation to the company's total capital (debt + equity), ranged from 0.40 to 0.49 during this period.

The trend analysis shows that the ratio experienced a decreasing trend from Q2 2022 to Q3 2023, indicating a reduction in the reliance on debt financing and an improvement in the company's capital structure during this period. However, the ratio slightly increased in Q4 2023 compared to the previous quarter.

Overall, the company's debt-to-capital ratio has been relatively stable, staying within the range of 0.40 to 0.49. Investors and creditors may view a lower ratio favorably as it suggests lower financial risk associated with excessive debt levels. However, it is essential to consider industry benchmarks and the company's specific circumstances when evaluating the implications of this ratio on Pediatrix Medical Group Inc's financial health.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-capital ratio
Mednax Inc
MD
0.00
Encompass Health Corp
EHC
0.00
Select Medical Holdings
SEM
0.00